Which patients need bisphosphonate therapy—and for how long?
Veronica Hackethal, MD
Although the screening controversy has been smoldering for some time, a recent article may have added fuel to the fire.
Help your patients help themselves. Take a look at 6 rheumatology apps you can discuss at the next visit.
Is there a role for probiotics in the management of rheumatoid arthritis?
Which patients with RA are at greatest risk?
Findings from the first real-world study of gaps in care for hypertension and dyslipidemia in patients with psoriasis and psoriatic arthritis.
Which treatments are effective—and which are unlikely to be helpful? Answers can be found here.
British investigators take a long-range view of tumor necrosis factor inhibitors in patients with psoriatic arthritis.
Norwegian researchers looked at the long-term prevalence of inflammatory back disorders in patients with IBD—and identified a predisposing factor.
Highlights of 5 topline news stories from the FDA, CDC, and American College of Rheumatology—with real-world implications for primary care practice.